Literature DB >> 17046996

Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition.

Ester Martín-Villar1, Diego Megías, Susanna Castel, Maria Marta Yurrita, Senén Vilaró, Miguel Quintanilla.   

Abstract

Podoplanin is a small membrane mucin expressed in tumors associated with malignant progression. It is enriched at cell-surface protrusions where it colocalizes with members of the ERM (ezrin, radixin, moesin) protein family. Here, we found that human podoplanin directly interacts with ezrin (and moesin) in vitro and in vivo through a cluster of basic amino acids within its cytoplasmic tail, mainly through a juxtamembrane dipeptide RK. Podoplanin induced an epithelial-mesenchymal transition in MDCK cells linked to the activation of RhoA and increased cell migration and invasiveness. Fluorescence time-lapse video observations in migrating cells indicate that podoplanin might be involved in ruffling activity as well as in retractive processes. By using mutant podoplanin constructs fused to green fluorescent protein we show that association of the cytoplasmic tail with ERM proteins is required for upregulation of RhoA activity and epithelial-mesenchymal transition. Furthermore, expression of either a dominant-negative truncated variant of ezrin or a dominant-negative mutant form of RhoA blocked podoplanin-induced RhoA activation and epithelial-mesenchymal transition. These results provide a mechanistic basis to understand the role of podoplanin in cell migration or invasiveness.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046996     DOI: 10.1242/jcs.03218

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  143 in total

1.  Increased lymphatic vessels in patients with encapsulating peritoneal sclerosis.

Authors:  Tatsuhiro Yaginuma; Izumi Yamamoto; Hiroyasu Yamamoto; Jun Mitome; Yudo Tanno; Keitaro Yokoyama; Takenori Hayashi; Tetsuya Kobayashi; Michiaki Watanabe; Yutaka Yamaguchi; Tatsuo Hosoya
Journal:  Perit Dial Int       Date:  2012-06-01       Impact factor: 1.756

2.  Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.

Authors:  Juan Carlos de Vicente; Tania Rodríguez Santamarta; Juan Pablo Rodrigo; Juana María García-Pedrero; Eva Allonca; Verónica Blanco-Lorenzo
Journal:  Virchows Arch       Date:  2015-03-01       Impact factor: 4.064

3.  Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

Authors:  Yukinari Kato; Ganesan Vaidyanathan; Mika Kato Kaneko; Kazuhiko Mishima; Nidhi Srivastava; Vidyalakshmi Chandramohan; Charles Pegram; Stephen T Keir; Chien-Tsun Kuan; Darell D Bigner; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2010-10       Impact factor: 2.408

4.  Proteomics analysis of the ezrin interactome in B cells reveals a novel association with Myo18aα.

Authors:  Ken Matsui; Neetha Parameswaran; Nayer Bagheri; Belinda Willard; Neetu Gupta
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

Review 5.  The lymphatic system in health and disease.

Authors:  Leah N Cueni; Michael Detmar
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

6.  Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.

Authors:  Kate L Lowe; Brenda A Finney; Carsten Deppermann; René Hägerling; Salomé L Gazit; Jon Frampton; Christopher Buckley; Eric Camerer; Bernhard Nieswandt; Friedemann Kiefer; Steve P Watson
Journal:  Blood       Date:  2015-04-23       Impact factor: 22.113

7.  The morphological and molecular features of the epithelial-to-mesenchymal transition.

Authors:  Gema Moreno-Bueno; Héctor Peinado; Patricia Molina; David Olmeda; Eva Cubillo; Vanesa Santos; José Palacios; Francisco Portillo; Amparo Cano
Journal:  Nat Protoc       Date:  2009-10-15       Impact factor: 13.491

8.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

9.  Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility.

Authors:  Harini Krishnan; Jhon A Ochoa-Alvarez; Yongquan Shen; Evan Nevel; Meenakshi Lakshminarayanan; Mary C Williams; Maria I Ramirez; W Todd Miller; Gary S Goldberg
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

10.  Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer.

Authors:  Agnes Assao; Suely Nonogaki; José Roberto Pereira Lauris; André Lopes Carvalho; Clóvis Antônio Lopes Pinto; Fernando Augusto Soares; Luiz Paulo Kowalski; Denise Tostes Oliveira
Journal:  Clin Oral Investig       Date:  2016-09-14       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.